Literature DB >> 22901384

Synthesis and evaluation of substituted hexahydronaphthalenes as novel inhibitors of the Mcl-1/BimBH3 interaction.

Young B Kim1, Maria E Balasis, Kenichiro Doi, Norbert Berndt, Courtney DuBoulay, Chih-Chi Andrew Hu, Wayne Guida, Hong-Gang Wang, Saïd M Sebti, Juan R Del Valle.   

Abstract

Mcl-1, an anti-apoptotic member of the Bcl-2 protein family, is overexpressed in a broad range of human cancers and plays a critical role in conferring resistance to chemotherapy. In the course of screening a natural product-like library of sesquiterpenoid analogs, we identified substituted hexahydronaphthalenes that showed activity against the Mcl-1/BimBH3 interaction in vitro. Here, we describe the synthesis of a small library of analogs and their biological evaluation. The most potent inhibitor in the series (19) exhibits an IC(50) of 8.3 μM by ELISA and disrupts the interaction between endogenously expressed Mcl-1 and Bim in cultured MDA-MB-468 breast cancer cells.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22901384      PMCID: PMC3432503          DOI: 10.1016/j.bmcl.2012.07.050

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  20 in total

Review 1.  The Bcl-2 apoptotic switch in cancer development and therapy.

Authors:  J M Adams; S Cory
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

2.  Structural insights into the degradation of Mcl-1 induced by BH3 domains.

Authors:  Peter E Czabotar; Erinna F Lee; Mark F van Delft; Catherine L Day; Brian J Smith; David C S Huang; W Douglas Fairlie; Mark G Hinds; Peter M Colman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-27       Impact factor: 11.205

Review 3.  The BCL-2 protein family: opposing activities that mediate cell death.

Authors:  Richard J Youle; Andreas Strasser
Journal:  Nat Rev Mol Cell Biol       Date:  2008-01       Impact factor: 94.444

4.  Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.

Authors:  Wolfgang Sieghart; Doris Losert; Sabine Strommer; Daniel Cejka; Katharina Schmid; Susanne Rasoul-Rockenschaub; Martin Bodingbauer; Richard Crevenna; Brett P Monia; Markus Peck-Radosavljevic; Volker Wacheck
Journal:  J Hepatol       Date:  2005-10-25       Impact factor: 25.083

5.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours.

Authors:  Tilman Oltersdorf; Steven W Elmore; Alexander R Shoemaker; Robert C Armstrong; David J Augeri; Barbara A Belli; Milan Bruncko; Thomas L Deckwerth; Jurgen Dinges; Philip J Hajduk; Mary K Joseph; Shinichi Kitada; Stanley J Korsmeyer; Aaron R Kunzer; Anthony Letai; Chi Li; Michael J Mitten; David G Nettesheim; ShiChung Ng; Paul M Nimmer; Jacqueline M O'Connor; Anatol Oleksijew; Andrew M Petros; John C Reed; Wang Shen; Stephen K Tahir; Craig B Thompson; Kevin J Tomaselli; Baole Wang; Michael D Wendt; Haichao Zhang; Stephen W Fesik; Saul H Rosenberg
Journal:  Nature       Date:  2005-05-15       Impact factor: 49.962

6.  BCL-2 gene family and the regulation of programmed cell death.

Authors:  S J Korsmeyer
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

Review 7.  Life in the balance: how BH3-only proteins induce apoptosis.

Authors:  Simon N Willis; Jerry M Adams
Journal:  Curr Opin Cell Biol       Date:  2005-10-21       Impact factor: 8.382

8.  The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.

Authors:  Aslamuzzaman Kazi; Jiazhi Sun; Kenichiro Doi; Shen-Shu Sung; Yoshinori Takahashi; Hang Yin; Johanna M Rodriguez; Jorge Becerril; Norbert Berndt; Andrew D Hamilton; Hong-Gang Wang; Saïd M Sebti
Journal:  J Biol Chem       Date:  2010-12-09       Impact factor: 5.157

9.  Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells.

Authors:  Lanxi Song; Domenico Coppola; Sandy Livingston; Doug Cress; Eric B Haura
Journal:  Cancer Biol Ther       Date:  2005-03-20       Impact factor: 4.742

Review 10.  Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels.

Authors:  Katherine E Ewings; Ceri M Wiggins; Simon J Cook
Journal:  Cell Cycle       Date:  2007-07-10       Impact factor: 4.534

View more
  4 in total

1.  Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design.

Authors:  Anders Friberg; Dominico Vigil; Bin Zhao; R Nathan Daniels; Jason P Burke; Pedro M Garcia-Barrantes; DeMarco Camper; Brian A Chauder; Taekyu Lee; Edward T Olejniczak; Stephen W Fesik
Journal:  J Med Chem       Date:  2012-12-17       Impact factor: 7.446

Review 2.  New dimension in therapeutic targeting of BCL-2 family proteins.

Authors:  Samaher Besbes; Massoud Mirshahi; Marc Pocard; Christian Billard
Journal:  Oncotarget       Date:  2015-05-30

3.  Synthesis and structure-activity relationship of coumarins as potent Mcl-1 inhibitors for cancer treatment.

Authors:  Yang-Liu Xia; Jing-Jing Wang; Shi-Yang Li; Yong Liu; Frank J Gonzalez; Ping Wang; Guang-Bo Ge
Journal:  Bioorg Med Chem       Date:  2020-11-07       Impact factor: 3.641

4.  Designed BH3 peptides with high affinity and specificity for targeting Mcl-1 in cells.

Authors:  Glenna Wink Foight; Jeremy A Ryan; Stefano V Gullá; Anthony Letai; Amy E Keating
Journal:  ACS Chem Biol       Date:  2014-07-23       Impact factor: 5.100

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.